• Serumsyge Serumsyge og serumsyge- lignende reaktioner, som er forskinkede type III allergiske reaktioner, er sjældent set hos patienter behandlet med humaniserede monoklonale antistoffer, inklusive omalizumab.
• Serum Sickness Serum sickness and serum sickness-like reactions, which are delayed allergic type III reactions, have rarely been seen in patients treated with humanized monoclonal antibodies including omalizumab.